Neuro-Luminance Brain Health Centers, Inc. announces today its Medical Director, and board certified psychiatrist Dr. Theodore Henderson, authored a new study published this week in Frontiers in Psychiatry, that shows another breakthrough in treating depression with only one side affect that counts: Feeling better.
The news wire report circulated on PRNewswire to more than 260 media outlets from around the world, coast-to-coast including several high-traffic news websites such as Markets Business Insider, Yahoo Finance, Market Watch, Seeking Alpha, Washington Business Journal, and the Denver Business Journal. The long-version of the story is available at TBI.care.
The observational study, “Multi-Watt Near-Infrared Phototherapy for the Treatment
of Comorbid Depression: An Open Label Single-Arm Study,” reported on 39 patients who had both traumatic brain injury (TBI) and depression. Following this revolutionary treatment, a staggering 82 percent of the patients from the study report being in remission – no longer having the symptoms of depression.
The non-invasive treatment in the study uses a “neuro laser” applied transcranially, and believed to rejuvenate damaged brain cells, improving brain metabolism, while reducing inflammation, oxidative stress and neurodegeneration — without any negative side effects. Co-Founders of Neuro-Laser Foundation, Dr. Henderson and Dr. Morries, have published five additional studies supporting the effectiveness of this treatment, particularly on patients with a traumatic brain injury.
Patients receiving the NILT treatment sit or lay comfortably during a series of 20-35 minute sessions in which the neuro-laser is applied by trained medical professionals. There is no skin irritation, pain, or unpleasant feelings. There are no other side effects, which have always been the downside of antidepressant medication including weight gain, drowsiness, even erectile dysfunction.
Dr. Henderson warns consumers about other “laser” treatments, as typically they feature a “low-level” or LED source which does not have any therapeutic effect. The device used in this study, which is the only one available for clinical use, features a high-powered, and multi-Watt near-infrared light (NILT).
Learn more at TBI.care, or schedule a consultation by calling 720-493-1101
Send email to email@example.com
Additional media reporting the story includes: WZVN-TV ABC-7 [Fort Myers, FL], WWBT-TV NBC-12 [Richmond, VA], Wichita Business Journal, WFMZ-TV IND-69 [Allentown, GA], KVVU-TV OX-29 [Las Vegas, NV], Washington Psychiatric Society, US Press Association, Senior Psychiatrists, San Jose Business Journal, Life Science Research, Kansas City Business Journal, Healthlinks, BioSpace, Baltimore Business Journal, Alliance Health Education Initiative, Assignment Editor, and the Chicago Business News.